We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$189M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$143M
3
MRK icon
Merck
MRK
+$136M
4
ABMD
Abiomed Inc
ABMD
+$124M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$124M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICUI icon
1876
ICU Medical
ICUI
$3.93B
– –
-328
Closed -$98K
IDCC icon
1877
InterDigital
IDCC
$6.68B
– –
-323
Closed -$33K
IMVT icon
1878
Immunovant
IMVT
$8.09B
– –
-243
Closed -$7K
INGN icon
1879
Inogen
INGN
$167M
– –
-856
Closed -$26K
INMD icon
1880
InMode
INMD
$872M
– –
-325
Closed -$38K
INO icon
1881
Inovio Pharmaceuticals
INO
$79.8M
– –
-441
Closed -$14K
INSW icon
1882
International Seaways
INSW
$4.57B
– –
-1,274
Closed -$97K
IOSP icon
1883
Innospec
IOSP
$2.09B
– –
-540
Closed -$95K
IRBT
1884
DELISTED
iRobot
IRBT
– –
-919
Closed -$55K
JLL icon
1885
Jones Lang LaSalle
JLL
$15.1B
– –
-804
Closed -$231K
JPM icon
1886
PUT
JPMorgan Chase
JPM
$939B
– –
-3,300
Closed -$345K
KFY icon
1887
Korn Ferry
KFY
$3.98B
– –
-1,395
Closed -$81K
KLIC icon
1888
Kulicke & Soffa
KLIC
$5.3B
– –
-813
Closed -$74K
KMT icon
1889
Kennametal
KMT
$2.68B
– –
-875
Closed -$48K
KNSA icon
1890
Kiniksa Pharmaceuticals
KNSA
$4.83B
– –
-4,020
Closed -$56K
KOD icon
1891
Kodiak Sciences
KOD
$2.59B
– –
-234
Closed -$4K
KROS icon
1892
Keros Therapeutics
KROS
$199M
– –
-1,372
Closed -$61K
KRYS icon
1893
Krystal Biotech
KRYS
$9.88B
– –
-382
Closed -$44K
KT icon
1894
KT
KT
$8.84B
– –
-210,130
Closed -$2.57M
KTB icon
1895
Kontoor Brands
KTB
$4.62B
– –
-1,114
Closed -$40K
MZTI
1896
The Marzetti Company
MZTI
$2.94B
– –
-346
Closed -$96K
LCII icon
1897
LCI Industries
LCII
$2.51B
– –
-264
Closed -$57K
LE icon
1898
Lands' End
LE
$361M
– –
-111
Closed -$1K
LEG icon
1899
Leggett & Platt
LEG
$1.52B
– –
-1,241
Closed -$83K
LGIH icon
1900
LGI Homes
LGIH
$1.4B
– –
-227
Closed -$36K
74 75
76
77 78

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.